Line between patent-protectable new medical indications and ineffective dietary supplements

This case (17 Ob 35/09k – 2 February 2010) concerned the infringement of a “Swiss-type” claim: “The use of an isoflavone phyto-oestrogen extract of soy or clover, for the manufacture of a medicament for administration in unit dosage form for the treatment of pre-menstrual syndrome, symptoms associated with menopause, or prostate cancer.” The defendant sold a product that … >> read more

01.08.2010
  • KEYWORDS

  • PERIOD

    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000